Skip to main content
OpenTrials

Clinical trial condition

HR-positive, HER2-negative Breast Neoplasms

Explore clinical trials studying HR-positive, HER2-negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

HR-positive, HER2-negative Breast Neoplasms trial results

Active, Not Recruiting

To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer

NCT05365178

Conditions
HR-positive, HER2-negative Breast Neoplasms
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 88 locations
View Trial Details